AD-3281 inhibits pathological neovascularization in preclinical models of neovascular AMD (nAMD), suggesting potential as a novel therapy

Back to ISVER 2025
Genetics & Basic Science
Previous E-Poster
Back to ISVER 2025
 Next E-Poster